The ophthalmic specialist wants to use the London-based company’s AI platform to address what it sees as critical care gaps in eye health.
Topcon Healthcare has invested in London-based health AI company Pangaea Data. The Tokyo-headquartered ophthalmic specialist wants to use Pangaea’s AI platform to address what it sees as critical care gaps in eye health and systemic disease.
Financial terms have not been disclosed.
Pangaea Data’s platform automatically analyses structured and unstructured patient records against clinical guidelines, emulating a clinician’s manual review, to uncover patients who meet diagnostic or treatment criteria but are not currently in a treatment or management process. Integrated directly into existing electronic health records and downstream scheduling systems, the platform enables real-time clinical action without disrupting workflows.
Through this partnership, Pangaea Data’s platform will create an interface with Topcon Healthcare’s digital health platform so that optometry and ophthalmology practices can identify patients who need follow-up or further evaluation.
This includes patients with conditions such as glaucoma and diabetic retinopathy many of who remain undiagnosed.
“Pangaea Data’s unique ability to find missed patients using AI, and to do so without burdening clinicians, has powerful implications for eye care and beyond,” said Ali Tafreshi, chief executive and president of Topcon Healthcare.
